The use of pneumococcal conjugate vaccines has been associated with a major reduction in mortality and morbidity from pneumococcal disease among young children worldwide, but these vaccines are costly. With the support of Gavi, the Vaccine Alliance, most low-income countries have introduced pneumococcal conjugate vaccines,1 but sustaining the…
The New England Journal of Medicine: Search Results in Infectious Disease
